Status:
UNKNOWN
Eeva™ Pregnancy Pilot Study (PPS)
Lead Sponsor:
Progyny, Inc.
Conditions:
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The purpose of this clinical investigation is to gather pilot data to evaluate the impact of using Eeva™, a time-lapse enabled embryo test, in combination with traditional morphology on clinical pregn...
Eligibility Criteria
Inclusion
- Women undergoing fresh in vitro fertilization treatment using their own eggs
- ≤ 40 years
- ≥ 4 diploid embryos (i.e. having 2 PNs)
- ≤ 3 Prior ART cycles (IVF, ICSI and related procedures)
- All 2PN embryos (for all 3 arms) must be imaged by Eeva
- Subject willing to comply with study protocol and procedures
- Subject willing to provide written informed consent
Exclusion
- Preimplantation genetic diagnosis or preimplantation genetic screening
- Planned "freeze all" cycle (eggs or embryos)
- Asherman's Syndrome
- Donor egg
- Gestational carrier
- Presence of Hydrosalpinx on ultrasound
- Concurrent participation in an interventional clinical study
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2016
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT02218255
Start Date
August 1 2014
End Date
June 1 2016
Last Update
October 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115